ReviewOrthopaedic surgery2026
Therapeutic Strategies and Clinical Outcomes of Infections Following Anterior Cruciate Ligament Reconstruction: A Narrative Review.
Review in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Anterior cruciate ligament reconstruction (ACLR) is a widely performed orthopedic procedure, yet postoperative infection, although rare, poses a significant threat to graft integrity and long-term joint function. This review specifically focuses on therapeutic strategies for ACLR-associated infections. Management strategies constitute the core of this review, centering on early surgical debridement, targeted antimicrobial therapy, and, in selected cases, graft retention or removal. Preventive and rehabilitative measures such as graft presoaking with vancomycin, strict intraoperative asepsis, and structured postoperative rehabilitation are also discussed. Long-term functional outcomes are often suboptimal, emphasizing the importance of timely rehabilitation and individualized care. Rather than providing an exhaustive diagnostic review, we highlight therapeutic decision-making and evidence-based treatment pathways, supplemented by stratified comparisons of prospective and retrospective clinical studies. Ongoing research into biofilm-targeting therapies is essential to optimize treatment protocols and minimize infection-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.